China Pharma Holdings Stock Price History

CPHI Stock  USD 0.20  0.01  5.26%   
Below is the normalized historical share price chart for China Pharma Holdings extending back to April 17, 2002. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of China Pharma stands at 0.20, as last reported on the 21st of November, with the highest price reaching 0.20 and the lowest price hitting 0.19 during the day.
IPO Date
17th of April 2002
200 Day MA
0.2838
50 Day MA
0.2314
Beta
0.711
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in China Stock, it is important to understand the factors that can impact its price. China Pharma is out of control at the moment. China Pharma Holdings secures Sharpe Ratio (or Efficiency) of 0.0119, which signifies that the company had a 0.0119% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for China Pharma Holdings, which you can use to evaluate the volatility of the firm. Please confirm China Pharma's Downside Deviation of 7.67, risk adjusted performance of 0.0176, and Mean Deviation of 4.27 to double-check if the risk estimate we provide is consistent with the expected return of 0.0835%.
  
The China Pharma's current Common Stock Shares Outstanding is estimated to increase to about 3.8 M, while Total Stockholder Equity is projected to decrease to under 7.1 M. . As of now, China Pharma's Price Fair Value is increasing as compared to previous years. China Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0119

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskCPHI
Negative Returns

Estimated Market Risk

 7.0
  actual daily
62
62% of assets are less volatile

Expected Return

 0.08
  actual daily
1
99% of assets have higher returns

Risk-Adjusted Return

 0.01
  actual daily
0
Most of other assets perform better
Based on monthly moving average China Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of China Pharma by adding China Pharma to a well-diversified portfolio.
Price Book
0.6603
Enterprise Value Ebitda
(225.89)
Price Sales
0.5914
Shares Float
7.9 M
Wall Street Target Price
3

China Pharma Stock Price History Chart

There are several ways to analyze China Stock price data. The simplest method is using a basic China candlestick price chart, which shows China Pharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceOctober 7, 20240.27
Lowest PriceSeptember 5, 20240.18

China Pharma November 21, 2024 Stock Price Synopsis

Various analyses of China Pharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell China Stock. It can be used to describe the percentage change in the price of China Pharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of China Stock.
China Pharma Price Daily Balance Of Power 1.00 
China Pharma Accumulation Distribution 5,200 
China Pharma Price Action Indicator 0.01 
China Pharma Price Rate Of Daily Change 1.05 

China Pharma November 21, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in China Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use China Pharma intraday prices and daily technical indicators to check the level of noise trading in China Stock and then apply it to test your longer-term investment strategies against China.

China Stock Price History Data

The price series of China Pharma for the period between Fri, Aug 23, 2024 and Thu, Nov 21, 2024 has a statistical range of 0.09 with a coefficient of variation of 11.06. The prices are distributed with arithmetic mean of 0.22. The median price for the last 90 days is 0.23. The company had 1:5 stock split on 6th of March 2024.
OpenHighLowCloseVolume
11/21/2024 0.19  0.20  0.19  0.20  103,991 
11/20/2024 0.19  0.20  0.19  0.19  383,021 
11/19/2024 0.19  0.21  0.18  0.19  417,892 
11/18/2024 0.18  0.20  0.18  0.19  233,171 
11/15/2024 0.20  0.20  0.18  0.19  279,742 
11/14/2024 0.20  0.20  0.20  0.20  138,603 
11/13/2024 0.20  0.21  0.19  0.20  238,123 
11/12/2024 0.20  0.21  0.18  0.20  322,130 
11/11/2024 0.19  0.21  0.19  0.20  336,526 
11/08/2024 0.23  0.23  0.19  0.20  981,832 
11/07/2024 0.24  0.24  0.21  0.23  460,015 
11/06/2024 0.24  0.25  0.21  0.22  1,019,258 
11/05/2024 0.25  0.26  0.24  0.25  268,028 
11/04/2024 0.25  0.26  0.25  0.26  277,164 
11/01/2024 0.26  0.26  0.25  0.26  508,567 
10/31/2024 0.26  0.26  0.24  0.26  218,091 
10/30/2024 0.25  0.26  0.24  0.26  527,894 
10/29/2024 0.24  0.27  0.23  0.26  535,975 
10/28/2024 0.24  0.25  0.23  0.24  356,194 
10/25/2024 0.24  0.24  0.24  0.24  172,768 
10/24/2024 0.24  0.25  0.24  0.24  301,452 
10/23/2024 0.25  0.26  0.24  0.24  242,941 
10/22/2024 0.23  0.25  0.23  0.25  261,148 
10/21/2024 0.25  0.26  0.23  0.24  262,192 
10/18/2024 0.25  0.26  0.24  0.25  426,601 
10/17/2024 0.26  0.26  0.24  0.25  176,694 
10/16/2024 0.23  0.25  0.23  0.25  228,104 
10/15/2024 0.25  0.25  0.23  0.23  348,629 
10/14/2024 0.24  0.25  0.23  0.25  120,041 
10/11/2024 0.24  0.24  0.22  0.24  349,084 
10/10/2024 0.23  0.25  0.23  0.24  341,890 
10/09/2024 0.24  0.25  0.22  0.23  178,303 
10/08/2024 0.27  0.27  0.24  0.24  547,949 
10/07/2024 0.26  0.28  0.25  0.27  969,415 
10/04/2024 0.26  0.27  0.24  0.25  272,945 
10/03/2024 0.25  0.26  0.22  0.26  1,375,732 
10/02/2024 0.22  0.26  0.22  0.26  1,263,593 
10/01/2024 0.23  0.24  0.20  0.22  525,168 
09/30/2024 0.25  0.25  0.22  0.24  1,014,591 
09/27/2024 0.26  0.26  0.23  0.24  1,789,112 
09/26/2024 0.22  0.25  0.22  0.24  977,768 
09/25/2024 0.22  0.22  0.21  0.22  66,370 
09/24/2024 0.21  0.22  0.21  0.22  37,765 
09/23/2024 0.21  0.22  0.20  0.21  49,696 
09/20/2024 0.21  0.22  0.21  0.22  37,567 
09/19/2024 0.23  0.23  0.21  0.22  174,987 
09/18/2024 0.21  0.23  0.21  0.23  230,776 
09/17/2024 0.20  0.23  0.20  0.23  296,234 
09/16/2024 0.22  0.22  0.19  0.19  305,331 
09/13/2024 0.23  0.23  0.20  0.23  256,016 
09/12/2024 0.23  0.24  0.20  0.23  882,974 
09/11/2024 0.19  0.24  0.18  0.24  1,869,356 
09/10/2024 0.18  0.19  0.18  0.19  384,093 
09/09/2024 0.18  0.18  0.17  0.18  24,539 
09/06/2024 0.18  0.18  0.17  0.18  99,156 
09/05/2024 0.18  0.20  0.18  0.18  286,979 
09/04/2024 0.19  0.20  0.19  0.19  258,026 
09/03/2024 0.21  0.21  0.18  0.19  119,209 
08/30/2024 0.20  0.21  0.20  0.20  40,005 
08/29/2024 0.21  0.22  0.19  0.21  139,334 
08/28/2024 0.21  0.21  0.19  0.20  54,301 

About China Pharma Stock history

China Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for China is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in China Pharma Holdings will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing China Pharma stock prices may prove useful in developing a viable investing in China Pharma
Last ReportedProjected for Next Year
Common Stock Shares Outstanding3.4 M3.8 M
Net Loss-3.1 M-3.2 M

China Pharma Stock Technical Analysis

China Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of China Pharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of China Pharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Premium Stories Now

   

Premium Stories

Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
All  Next Launch Module

China Pharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for China Pharma's price direction in advance. Along with the technical and fundamental analysis of China Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of China to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for China Stock analysis

When running China Pharma's price analysis, check to measure China Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Pharma is operating at the current time. Most of China Pharma's value examination focuses on studying past and present price action to predict the probability of China Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China Pharma's price. Additionally, you may evaluate how the addition of China Pharma to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Global Correlations
Find global opportunities by holding instruments from different markets
Stocks Directory
Find actively traded stocks across global markets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format